Exelon (EXC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...
Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...